Media stories about Nobilis Health Corp (NYSE:HLTH) (TSE:NHC) have been trending somewhat positive on Tuesday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Nobilis Health Corp earned a coverage optimism score of 0.06 on Accern’s scale. Accern also assigned news headlines about the healthcare company an impact score of 46.7986238057655 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Here are some of the news headlines that may have effected Accern Sentiment’s rankings:

Nobilis Health Corp (NYSE:HLTH) traded up 1.562% during trading on Tuesday, reaching $1.625. 202,137 shares of the company’s stock were exchanged. The stock has a market capitalization of $126.43 million and a price-to-earnings ratio of 14.009. The company’s 50 day moving average price is $1.75 and its 200-day moving average price is $1.74. Nobilis Health Corp has a 52 week low of $1.10 and a 52 week high of $3.86.

Nobilis Health Corp (NYSE:HLTH) (TSE:NHC) last issued its quarterly earnings data on Wednesday, August 2nd. The healthcare company reported $0.02 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.01 by $0.01. The firm had revenue of $79.96 million during the quarter, compared to analyst estimates of $69.89 million. On average, equities analysts expect that Nobilis Health Corp will post $0.14 EPS for the current year.

Nobilis Health Corp declared that its board has approved a stock buyback plan on Tuesday, May 2nd that authorizes the company to buyback 4,000,000 shares. This buyback authorization authorizes the healthcare company to purchase shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board of directors believes its shares are undervalued.

A number of equities analysts have weighed in on HLTH shares. Zacks Investment Research downgraded shares of Nobilis Health Corp from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 20th. Benchmark Co. started coverage on shares of Nobilis Health Corp in a research note on Friday, May 19th. They set a “buy” rating and a $2.50 price target on the stock. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $2.70.

ILLEGAL ACTIVITY WARNING: This story was first published by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at

About Nobilis Health Corp

Nobilis Health Corp. (Nobilis) owns and manages healthcare facilities in the States of Texas and Arizona, consisting primarily of ambulatory surgery centers (ASCs) and acute-care and surgical hospitals. The Company’s segments include Medical Services, Marketing Services and Corporate. The Medical Services segment owns and manages approximately nine healthcare facilities in Texas and Arizona; over four hospitals, and approximately five ambulatory surgery centers.

Insider Buying and Selling by Quarter for Nobilis Health Corp (NYSE:HLTH)

Receive News & Ratings for Nobilis Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nobilis Health Corp and related companies with's FREE daily email newsletter.